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Abstract
Operations Research has a successful tradition of applying mathematical analysis to a wide
range of applications, with one of the burgeoning areas of growth being in medical physics. The
original application was in the optimal design of the fluence map for a radiotherapy treatment,
a problem that has continued to receive attention. However, operations research has been
applied to other clinical problems like patient scheduling, vault design, and image alignment.
The overriding theme of this article is to present how techniques in operations research apply
to clinical problems, which we accomplish in three parts. First, we present the perspective
from which an operations research expert addresses a clinical problem. Second, we succinctly
introduce the underlying methods that are used to optimize a system, and third, we demonstrate
how modern software facilitates problem design. Our discussion is tethered to recent publications
to foster continued study.

1

Introduction

Operations research (OR) is an area of study that focuses on the analysis of decision making.
The field was born out of the military need to improve the efficiency of “operations” during
the second world war, but the associated methods of modeling, optimizing, and analyzing real
world phenomena have found a spectrum of applications across a range of disciplines. A recent
area of interest is the application of OR to medicine, and most notably, to the optimal design
of a radiotherapy treatment. The original suggestion to optimize the design process was made
in 1968 [3]. This early publication shows that the medical physics community recognized the
use of OR long before the OR community recognized the applications in medical physics. However, in the 1990s the operations research community became aware of the array of important
applications in medical physics, and today there is a devoted collection of OR experts whose
primary interests lie in the study of applying OR to problems in medical physics.
Through the authors’ professional interactions, we have observed that the OR and medical
physics communities approach problems from different perspectives, and one of the goals of this
article is to address the questions of, How and why is OR beneficial to problems in medical
physics? One of the main differences in research methodologies is that the OR community uses
a rich taxonomy of problem classes that are individually well studied in their mathematical
abstraction, and when a problem in medical physics is considered by an OR expert, one of the
initial objectives is to model the problem so that it becomes a member of one of these classes.
As such, we are not immediately concerned with solving the problem but are instead interested
in modeling and classifying it as a member of a known class. Once a problem is modeled, we

address how to use (or solve) the model, but since it is a member of a specified class, we can
likely use or adapt the solution methods developed for the class. We often continue by analyzing
the results to better understand their value to the application. So from an OR perspective, the
general research process is to model, solve, and analyze against an underlying taxonomy of well
known problems. Of course, not every problem fits nicely within the taxonomy, and in this case,
the OR expert has to either combine known methods or invent new ones, and in either case, the
field of OR benefits from new insights. This type of work similarly follows the central process
of modeling, solving and analysis, and it is this methodology that we hope to convey.
One of the advantages of addressing a problem through the lens of OR is that we can harness
the professional expertise of years of prior research, which is often embodied in state-of-the-art
software. This routinely alleviates the OR expert from the tedious development of software to
address a particular problem. Instead, a problem can be modeled with professional software that
is linked to advanced algorithms. This streamlines problem solving and facilitates investigation
since altering and solving a model are seamless. Examples of this solution approach are presented
throughout.
Consistent with the OR perspective, we have organized the remainder of the paper as follows.
Section 2 considers convex problems in medical physics. We continue with a discussion of discrete
problems in Section 3, which is followed by a collection of other problem formats in Section 4.
Section 5 discusses the important idea of considering multiple, and often competing, objectives.
Each section points to problems in medical physics that have been modeled as a member of the
associated problem class. Moreover, each section explains how to recognize whether or not the
abstraction of a real-world phenomena can be appropriately modeled as a member of a class.
Information about software and solution analysis is also included.
We mention that several reviews of medical physics applications already exist in the OR
literature, and we point readers to [16] as a modern and sweeping review. Our exposition is
different because it focuses more on the OR methods for medical physicists instead of focusing
on the applications for the OR community. Any reader who would like to learn more about OR
and optimization is pointed to the classic text of [23].

2

Convex Problems

The study of convex optimization is arguably at the foundation of the field of optimization.
There are two reasons, 1) many real-world problems naturally fall into this category, and 2)
convexity is a mathematical property that allows us to prove the optimality of a solution. The
general form is
min{f (x) : x ∈ X},
(1)

where f is a convex function and X is a convex set. The problem asks us to find the smallest
value of f , called the objective function, over the collection of vectors in X. The set X is convex
if for all x and y in X, we have that the line segment between them is also in X, i.e.
(1 − αx) + αy ∈ X,

provided that 0 ≤ α ≤ 1. The set X is called the feasible region and is commonly defined
functionally as X = {x : g(x) ≤ 0}. In this case the set X is convex if and only if g is a convex
function, and (1) becomes
min{f (x) : g(x) ≤ 0}.
(2)

Beginning calculus students learn an intuitive definition of convexity, which states that a function
is convex if it’s second derivative is positive. Such intuition is overly restrictive since it only
considers real-valued, twice differentiable functions of a single variable. Instead, we let x be a
vector of length n and use a definition that weakens the differentiability condition. A real-valued
function is convex if
f ((1 − α)x + αy) ≤ (1 − α)f (x) + αf (y),
(3)

for any x and y and in the function’s domain and any α satisfying 0 ≤ α ≤ 1. This condition
essentially states that the line segment between (x, f (x)) and (y, f (y)) is above the function.
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The definition requires no differentiability, although it is worth mentioning that it does imply
continuity and nearly differentiability. If f is thrice differentiable, this condition is the same as
the eigenvalues of the Hessian being non-negative, which reduces to the intuitive definition from
calculus. The function is strictly convex if the inequality in (3) holds strictly for 0 < α < 1.
The function g need not be single valued, and in general, we assume that g maps the n-vector x
to the m-vector (g1 (x), g2 (x), . . . , gm (x))T . In this case, g is convex if each component function
gi (x) is convex.
Joseph-Louis Lagrange considered optimization problems like (2) in the middle of the 18th
century, and his investigation provided the essential insights needed to solve problems. The
function underlying the theoretical development bears his name and is
L(x, λ) = f (x) − λT g(x).
After years of study by great minds like von Neumann, the core theory to solve optimization
problems with digital computation was complete. Without a foray into the theoretical development, the theme is that under the assumption that f and g have suitably nice analytic
conditions, we have that if x∗ is an optimal solution to (2), then there is a λ∗ so that
g(x∗) ≤ 0, ∇f (x∗ ) − (λ∗ )T ∇g(x∗ ) = 0, and (λ∗ )T g(x∗) = 0.

(4)

These are often called the first order (necessary) Lagrange conditions for optimality. Alone,
these equations do not classify optimality since they may have solutions that are not optimal.
However, if f and g are convex, then these equations are satisfied if and only if x∗ is optimal,
which is the quintessential reason convex problems are important. This means solving a convex
optimization problem is the same as solving (4).
Convex problems often arise in medical physics as deviation problems. A prominent example
is the optimal design of a fluence map. If we let x represent the fluence over a collection of angles
and D(x) be the linear operator that maps fluence into dose, then a simple treatment design
problem is
min {kD(x) − T kp : x ≥ 0} .
(5)

A bit of book keeping is needed to make sense of this model. The vector D(x) is usually
segmented into sub-vectors that give the dose to the target, organs-at-risk, and normal tissues,
and the corresponding sub-vectors of T represent the target amounts for each of the tissues,
which are normally zero except for the target. A solution to the model finds a fluence pattern x
that minimizes the deviation from the desired dose T . We mention that deviations for different
tissues are often considered individually and weighted to form an objective. The problem is
then an instance of a multiple objective problem, a topic that is developed in Section 5.
The parameter p defines the norm that is used to measure the deviation, and the 3 cases
ofPp being 1, 2 and ∞ are common. For p = 1 and p = 2, we have that kD(x) − T kp =
p 1/p
( m
. In particular, if p = 1, the problem is linear, and if p = 2, the problem
i=1 |Di (x) − Ti | )
is quadratic and asks us to find a least squares solution. For p = ∞, we have kD(x) − T kp =
max{|Di (x)−Ti | : i = 1, 2, . . . , m}, which means the problem minimizes the maximum deviation.
This is again a linear problem.
All three models are convex, and all three can be solved by satisfying (4). We detail the case
for p = ∞. If we let A be the matrix so that D(x) = Ax, then (5) can be re-written as follows,
min {kAx − T k∞ : x ≥ 0} ⇔ min {z : −ze ≤ Ax − T ≤ ze, x ≥ 0, z ≥ 0} ,
where e is a vector of ones of necessary length and z is an added variable that measures the
maximum deviation through the constraint −ze ≤ Ax − T ≤ ze. The model on the right is
linear, and in this case, the necessary and sufficient conditions in (4) become the following
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system of (in)equalities,
Ax + ze
−Ax + ze

AT λ′ − AT λ′′
T

′

T

e λ +e λ

′′

(Ax − ze − T )T λ′ + (−Ax + ze + T )T λ′′

x, z, λ′ , λ′′

≥

≥

≤

≤

T

(6)

−T

(7)

0

(8)

1

(9)

=

0

(10)

≥

0.

(11)

We reiterate that any solution (x, z, λ′ , λ′′ ) gives an optimal solution of z because the problem
is convex. Similar systems exist for the p = 1 and p = 2 cases.
If the original problem is strictly convex, then we can prove that systems like (6) through
(11) have a unique solution. This is the case for p = 2 (least-squares), which is one of the
advantages of the 2-norm. However, this is not generally a good reason to use the 2-norm.
Indeed, the norm should be selected to best approach the situation. For example, we know the
maximum deviation from our prescribed dose if we solve the problem with the infinity-norm.
If the deviation is minuscule, then we have likely achieved a favorable fluence pattern. Such
a guarantee is not available with other norms. The optimal value of the problem with the 1norm, divided by the number of voxels, is the minimum average deviation, which may include
a few large deviations that are balanced against several small deviations. The 2-norm has the
same behavior, although it places greater emphasis on decreasing large deviations. In general,
larger values of p decrease large deviations, with the ultimate value of p = ∞ minimizing the
largest deviation. From a modeling perspective, the value of p should be selected to fit the
desired emphasis on large deviations. For a fluence problem, it might make sense to minimize
the infinity-norm first, and if the value is small, the treatment could be accepted. If the value
is large, then we have gained the knowledge that large deviations from the prescribed dose
are necessary, and we might proceed with a subsequent solve with the 1 or 2-norm to find an
optimal fluence pattern that counters large deviations with a preponderance of small deviations.
Of course, a treatment planner would need to inspect the spatial position of the deviations to
ensure a standard of care. Restricting dose volumetrically and spatially can be achieved with
additional constraints, some of which are addressed in the next section.
The special case of linear programming is important to many areas of optimization since
we often use successive linear approximations or relaxations to solve a problem even if it is not
linear. For this reason a few words about linear programming are important. Linear programs
are not strictly convex, which means that we can not generally guarantee a unique solution to
a system like (6) through (11). In particular, an important but often overlooked fact is that
different algorithms often terminate with different solutions. The source of this issue can be
succinctly described in reference to the necessary and sufficient Lagrange conditions. Almost all
solution procedures divide the system into the three categories of primal feasibility, (6) & (7)
with the nonnegativity of x and z; dual feasibility, (8) & (9) with the nonnegativity of λ′ and λ′′ ;
and complementarity, (10). The general attack is to satisfy two of the three categories and search
for the third. A primal method, such as the primal simplex method, satisfies primal feasibility
and complementarity and searches for dual feasibility, at which point it stops. A dual method
instead satisfies dual feasibility and complementarity and searches for primal feasibility. Interior
point methods satisfy primal and dual feasibility and search for complementarity. Since different
methods solve the system differently, it is easy to understand how alternative algorithms can
render different optimal solutions to the same problem.
Many users of optimization are interested in an algorithm’s speed, but the solution’s characteristics should also be considered. For example, in [18] it is shown that the dual simplex
method, which is commonly the fastest option, tends to group fluence so that a few angles deliver large amounts of unacceptable dose. The interior point methods, which are provably more
efficient in the worst-case, tend to distribute fluence over many angles. Although each algorithm
is efficient on real problems, the characteristics of the optimal solutions vary significantly. We
suggest selecting a solution method and model that fits the desired outcome.
Linear programming has also appeared opaquely in medical physics [24, 45]. As an example,
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the biological objective of maximizing the probability of tumor control is used in [43], but this
objective is the exponential of a linear function. Since the exponential is strictly monotonic,
optimizing the biological objective gives the same solution as optimizing the linear function.
Similar biological objectives also equate to linear programs.
We turn our discussion to how modeling and solving are separate but linked entities in
OR. We demonstrate some of what we have discussed above by adapting a simple fluence model
like (5). The data needed for the problem is the dose matrix A and the prescription T . Since the
same problem is used for illustrative purposes in the more challenging problems of later sections,
we consider a much simplified version from what would be clinically meaningful. However, the
observations based on these simplified examples extend to more realistic problems. The point
of the example is to show how an OR expert models and solves a problem. Our examples
are based on the Modeling software AMPL c , which links to a suite of different numerical
solvers. If not stated, we used CPLEX c as our solver. All examples may be downloaded
from www.InsertWebLink. We consider the acoustic neuroma depicted in Figure 1. A small
pencil beam model was used to calculate dose [33], and the prescription, which comprised the
parameter T , was to deliver 60 units of dose to the target and none to the remaining tissues.
The image was divided into a grid of 50 × 50 voxels (3mm thickness). Upon relabeling, the first
9 voxels were the target, the following 14 voxels were the left eye socket, the next 33 voxels were
the brain stem, and the last 998 voxels were the remaining tissue, referred to as the normal
tissue. We consider 6 equispaced angles, each with 10 pencils, of which only those delivering
significant dose to the target were used. This left 51 pencils whose fluence was to be decided.
The deviation model in (5) is too simplistic to interpret clinically since it treats all voxel
deviations the same. For example, if p = 1, the objective is to minimize the sum of deviations,
and hence, large anatomical structures dominate the design process. Since the normal tissue
has the preponderance of voxels, the optimal solution to (5) is x = 0 if p = 1, i.e. the optimal
treatment is no treatment. Similar issues arise if p = 2 or p = ∞. So that our solutions impart
some clinical interpretation, we alter (5) to become
min {λP T V kDP T V (x) − TP T V kp + λST M kDST M (x) − TST M kp

+λEY E kDEY E (x) − TEY E kp + λN RM L kDN RM L (x) − TN RM L kp : x ≥ 0} .

(12)

The subscripts P T V , ST M , EY E, and N RM L indicate the dose and prescription levels for the
target (P T V ), the brain stem (ST M ), the left eye socket (EY E), and the remaining normal
tissue (N RM L). This model remains convex but distinguishes between deviations in different
tissues. The λ scalars allow us to weight the importance of the different tissues. This model is
a scalarization of a multiple objective problem; a problem class covered in Section 5.
The code in Figure 1 illustrates the simplicity of creating a model with modeling software.
These 22 lines are all that is needed to generate a 2-norm version of (12). Importantly, this
model statement is independent of problem size, which is dictated by the size of the data and not
the mathematical relationships of the model. The data is located in another file, and although
this would change for different patients, different prescriptions, and different model parameters,
this same model statement would work as long as the goal is to solve the associated 2-norm
problem. The first 10 lines of code define the index sets used to describe the problem’s data.
The set ANGLES indexes the angles, BEAMS indexes the sub-beams (sometimes called bixels)
in each angle, and PENCILS is a collection of angle, sub-beam pairs. The VOXEL sets are
similar. The param commands inform AMPL to expect a matrix A, whose rows are indexed by
VOXELS and whose columns are indexed by PENCILS. A target dose T is also expected. Each
pencil has an associated variable that represents its fluence. The vector of nonnegative variables
is labeled x in the model statement. The objective is named “Deviation” and is the square of
the 2-norm. The λ scalars multiply the deviations for the target and the brain stem by 10 per
voxel - notice that we divide by the number of voxels in each structure, i.e. we divide by the
cardinality (card) of each voxel set. Similarly, deviations in the eye socket are multiplied by 1
per voxel and by 1/10 per voxel in the remaining tissue. Figures 2 and 3 show similar code for
the 1- and infinity-norms, and readers should notice their similarity.
The solution to the infinity-norm problem delivered 497.81 monitor units along angle 60◦ ,
which gave a maximum deviation of 1.06 Gy from the desired 60 Gy to the target. The brain
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2-Norm
set
set
set
set
set
set
set
set
set
set

TISSUES;
ANGLES;
BEAMS;
PENCILS within ANGLES, BEAMS;
VOXELS;
EYEVOXELS within VOXELS;
BRNSTMVOXELS within VOXELS;
TARGETVOXELS within VOXELS;
OARVOXELS within VOXELS;
NORMALVOXELS within VOXELS;

param A VOXELS, PENCILS;
param T VOXELS;
var x PENCILS >= 0;
minimize Deviation:
(10 / card(TARGETVOXELS)) * sum {v in TARGETVOXELS}
((sum{(a,i) in PENCILS} A[v,a,i]*x[a,i]) - T[v])ˆ2 +
(10 / card(BRNSTMVOXELS)) * sum {v in BRNSTMVOXELS}
((sum{(a,i) in PENCILS} A[v,a,i]*x[a,i]) - T[v])ˆ2 +
(1 / card(EYEVOXELS)) * sum {v in EYEVOXELS}
((sum{(a,i) in PENCILS} A[v,a,i]*x[a,i]) - T[v])ˆ2 +
(0.1 / card(NORMALVOXELS)) * sum {v in NORMALVOXELS}
((sum{(a,i) in PENCILS} A[v,a,i]*x[a,i]) - T[v])ˆ2;

Figure 1: The figure on the left depicts the acoustic neuroma used for our examples. On the right,
AMPL code for the 2-norm deviation model in (12).
stem received as high as 57.54 Gy and the normal as much as 62.86 Gy. The eye socket received
no significant radiation. The 2-norm problem similarly used only 60◦ , but at the lower amount of
336.28 monitor units. This gave an under treatment of 30.60 Gy on the target but a maximum
dose of 48 Gy for the brain stem. The 1-norm instead delivered 309.54 monitor units along
angle 60◦ and 114.17 monitor units along angle 240◦ , which were opposing angles. This gave
a maximum deviation in the target of 12.04 Gy and maximum dose to the brain stem of 59.68
Gy. Each of these models could be altered to represent a myriad of clinical desires, such as
dose-volume constraints, hard prescription bounds that must be enforced, the restriction to
non-opposing angles, etc.... The point we emphasize here is that the fundamental models along
with their more meaningful extensions are easily created within a modeling environment, and
we hope that readers will consider such systems as they continue their research. The benefits
are threefold: 1) models are built with a common language that facilitates dissemination, 2)
natural research questions are easily posed and answered by varying the model statement, and
3) several different solvers can be used on the same model. This allows a user to experiment
with different model and solver combinations to see how they effect the treatment.
We close this section with a brief discussion of recent uses of convex optimization in the
literature. Both linear and quadratic models have been suggested to optimize fluence, see [16]
as a review. Most of these models are extended versions of (5). Additional techniques are found
in [9, 34, 44, 54], which adapt probabilistic measures to control dose. These models are discussed
in Section 4. Deviation problems are also used for image alignment and comparison [42], and
have also been used for vault design [32].

3

Discrete Problems

Discrete optimization problems arise when the feasible region X in (2) is discrete, i.e. finite or
countable set. Typically, this means that the decision variables are restricted to take only integer
values. More precisely, optimization problems with only 0-1 variables and only integer variables
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1-Norm
set
set
set
set
set
set
set
set
set
set

TISSUES;
ANGLES;
BEAMS;
PENCILS within {ANGLES, BEAMS};
VOXELS;
EYEVOXELS within VOXELS;
BRNSTMVOXELS within VOXELS;
TARGETVOXELS within VOXELS;
OARVOXELS within VOXELS;
NORMALVOXELS within VOXELS;

param A {VOXELS, PENCILS};
param T {VOXELS};
var z {VOXELS} >= 0;
var x {PENCILS} >= 0;
minimize Deviation:
(10 / card(TARGETVOXELS)) * sum {v in TARGETVOXELS} z[v] +
(10 / card(BRNSTMVOXELS))* sum {v in BRNSTMVOXELS} z[v] +
(1 / card(EYEVOXELS)) * sum {v in EYEVOXELS} z[v] +
(0.1 / card(NORMALVOXELS)) * sum {v in NORMALVOXELS} z[v];
subject to TrgtDeviationUpBound {v in TARGETVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] <= z[v];
subject to EyeDeviationUpBound {v in EYEVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] <= z[v];
subject to BrnStmDeviationUpBound {v in BRNSTMVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] <= z[v];
subject to NrmlDeviationUpBound {v in NORMALVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] <= z[v];
subject to TrgtDeviationLowBound {v in TARGETVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] >= -z[v];
subject to EyeDeviationLowBound {v in EYEVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] >= -z[v];
subject to BrnStmDeviationLowBound {v in BRNSTMVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] >= -z[v];
subject to NrmlDeviationLowBound {v in NORMALVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] >= -z[v];

Figure 2: AMPL code for the 1-norm deviation problem in (12).

are called binary and integer optimization problems, respectively. Some optimization problems contain both continuous and integer variables and are called mixed integer optimization
problems. Integer variables are used when modeling quantities that can only occur in discrete
amounts, binary variables model yes/no decisions and are particularly versatile for modeling logical statements, e.g., when selecting from a set of options the statement “if option A is selected
then option B must be selected too” translates to xA − xB ≤ 0 for binary decision variables xA
and xB that take value one if option A, respectively B, are selected and zero otherwise. Binary
variables also allow counting by summation and can be used as “master” variables to control
the values of other “slave” variables in a model.
Discrete optimization problems are harder to solve than convex optimization problems because the tools of convex optimization are no longer available due to the fact that the feasible
region is no longer convex. This drawback is severe when the objective function f or the
constraints g are nonlinear, however, many problems that appear in applications have linear objectives and constraints. Hence, in what follows we only discuss discrete optimization problems
with linear constraints and objective functions and refer to these as integer programmes. We
let f (x) = cT x, where c is a n-vector called the cost vector, and g(x) = Ax − b, where A is a
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Infinity-Norm
set
set
set
set
set
set
set
set
set

TISSUES;
ANGLES;
BEAMS;
PENCILS within {ANGLES, BEAMS};
VOXELS; set EYEVOXELS within VOXELS;
BRNSTMVOXELS within VOXELS;
TARGETVOXELS within VOXELS;
OARVOXELS within VOXELS;
NORMALVOXELS within VOXELS;

param A {VOXELS, PENCILS};
param T {VOXELS};
var z {TISSUES} >= 0;
var x {PENCILS} >= 0;
minimize Deviation:
10*z[“TARGET”] + 10*z[“BRNSTM”] + 1*z[“EYE”] + 0.1*z[“NORMAL”];
subject to TrgtDeviationUpBound {v in TARGETVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] <= z[“TARGET”];
subject to EyeDeviationUpBound {v in EYEVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] <= z[“EYE”];
subject to BrnStmDeviationUpBound {v in BRNSTMVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] <= z[“BRNSTM”];
subject to NrmlDeviationUpBound {v in NORMALVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] <= z[“NORMAL”];
subject to TrgtDeviationLowBound {v in TARGETVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] >= -z[“TARGET”];
subject to EyeDeviationLowBound {v in EYEVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] >= -z[“EYE”];
subject to BrnStmDeviationLowBound {v in BRNSTMVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] >= -z[“BRNSTM”];
subject to NrmlDeviationLowBound {v in NORMALVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] - T[v] >= -z[“NORMAL”];

Figure 3: AMPL code for the infinity-norm deviation problem in (12).

m × n-matrix and b is a m-vector. The optimization problem
min{cT x : Ax ≤ b, x integer}
is called an integer programme (IP).
There are two main strategies to solve integer programming problems, namely branch and
bound algorithms and cutting plane algorithms. Branch and bound algorithms follow a “divideand-conquer” strategy. A division of the feasible set X is a set {X1 , . . . Xs } of subsets of X such
that X = X1 ∪ X2 ∪ . . . , ∪Xs . The optimal solution of the original problem must be the best of
the optimal solutions of the subproblems min{cT x : x ∈ Xi }. This subdivision scheme is applied
recursively and constitutes the branching part of the algorithm. It can be visualized in a branch
and bound tree, with nodes representing subproblems and branches representing the division of
a problem into subproblems. The recursion stops whenever a) a subproblem is infeasible, i.e.
Xi = ∅, b) an optimal (integer) solution for the subproblem is known, or c) the optimal (integer)
solution of the subproblem is guaranteed to be worse than the optimal solution of the original
problem. The branching part and the bounding in c) can be implemented in many ways and
are very often designed specifically for a particular problem.
The most common type of branch and bound is linear programming based branch and
bound. In this strategy to solve an integer program min{cT x : Ax ≤ b, x ∈ Zn }, the integrality
constraints are initially omitted (relaxed). The resulting linear program is solved, which gives a
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lower bound on the value of the IP. Next, a variable which has a fractional value in the optimal
solution is chosen and two subproblems are created, one with the added constraint that the
variable has to be less than or equal to its current value rounded down to the next lower integer,
one with the added constraint that the variable has to be greater than or equal to its current
value rounded up to the next higher integer. This branching partitions the feasible region of
the IP into two disjoint subsets. Imposing such bounds recursively eventually results in the
discovery of integer feasible solutions. Once a feasible solution to the original IP is known, it
is possible to check condition c) by comparing its value with that of any optimal solution of a
subproblem. If the latter is bigger, then no further subdivision of that subproblem needs to be
done because an optimal solution cannot be found in the subproblem. Since the LP relaxation
of any subproblem is a lower bound on its optimal value, it is sufficient to check whether the
optimal value of the LP relaxation is larger than the value of the best known feasible solution
(the incumbent).
Cutting plane algorithms also start by solving the LP relaxation of the IP. If this leads to
a fractional optimal solution, new constraints are added to the problem, which is re-solved. At
least one of the added constraints must be violated by the current optimal solution (which is
therefore cut off from the feasible set, hence the name cutting plane), yet all integer solutions
must remain feasible. This process continues until an integer optimal solution is found. In order
to be effective, the selection of constraints to be added is crucial. Modern solver software for
IPs can automatically generate many types of constraints automatically, but for many integer
programming problems, specific classes of constraints that are derived form the structure of the
model are needed to successfully solve problems of practically relevant size.
It is possible, and often necessary, to combine branch and bound algorithms with cutting
plane algorithms, which yields branch and cut algorithms. Here cutting planes are introduced
at every node of the branch and bound tree, i.e. in every subproblem.
For very large integer programs it may be impossible to include all variables in the model
from the start. Linear programming relaxations can then be solved with subsets of variables
and new variables generated whenever necessary. Whether additional variables contribute to an
improvement of the objective function can be determined by calculating their so called reduced
cost, a measure of how much they would contribute to the improvement of the objective function.
This step is called “pricing” variables. The inclusion of procedures to generate columns in branch
and bound or branch and cut algorithms is called branch and price, and respectively, branch and
cut and price. We refer readers to [31, 53] for a thorough introduction to integer programming.
In radiation oncology (mixed) integer optimization models appear mainly in three areas:
1) the beam selection problem, 2) the fluence map optimization problem in order to model
dose volume constraints, and 3) the segmentation problem. We explain each of these in some
detail below. A fourth problem related to radiation oncology where integer programming can
be used is the scheduling of treatments and handling of patient wait lists. This is a more
traditional management type of application of Operations Research that has received relatively
little attention [10, 26, 37]. [10] presents a model to schedule treatments over a period of six
days with the objective to maximize the number of new patients starting treatment (and thus
reduce the waiting list) and the sum of booked appointments.
A thorough discussion and survey of existing literature on the beam optimization problem
can be found in [18]. Here, we show how to incorporate beam angle optimization in fluence map
optimization problems. In the beam selection problem we can assume that the gantry may be
positioned in a given set A of positions (or beam angles) relative to the patient (e.g. in 360
stops on a full circle around the isocenter of the PTV in a coplanar treatment), at most R of
which are to be chosen for treatment. We index the possible directions by a and define binary
variables wa as follows:

1 if angle a is used
wa =
0 otherwise.
P
Then the number of beams to be selected can be controlled by the constraint a∈A wa ≤ R.
It is important to note that if the quality of a set of beam angles is measured by the optimal
value of a fluence map optimization problem it can be shown mathematically that, under very
general and reasonable conditions, using more angles can never degrade a treatment [18].
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Other constraints that can easily be modeled arePthe avoidance of opposing beams a1 and
a2 by za1 + za2 ≤ 1, minimal spacing of beams by a′ ∈U (a) za ≤ 1, where U (a) is the set of
beams in a neighborhood of a from which only one should be selected. Moreover, if we consider
continuous fluence variables, say x, constraints of the form xai ≤ M wa ensure that the fluence
of any bixel (a, i) of beam a is 0 whenever that beam is not selected to be used for treatment, i.e.
wa = 0. The optimization of beam angles can be easily included in any such fluence problem.
The AMPL models of Figures 1, 2 and 3 only need the few additional lines shown in Figure 4.
We remark that the solutions of our fluence map optimization example in Section 2 only used
one or two angles anyway, so that the addition of the beam selection constraints would have
had no effect.

Beam Angle Optimization
var w {ANGLES} binary;
param R;
param M;
subject to Numangles: sum {a in ANGLES} w[a] <= R;
subject to Switch-off {(a,i) in PENCILS}: x[a, i] <= M * w[a];

Figure 4: AMPL code for including beam angle optimization in fluence map optimization models.
Dose volume constraints typically impose that at most q% of the volume of an organ at risk
may receive a dose greater than p Gy. From an OR perspective such a constraint is naturally
modeled using integer variables. The discretization of the patient volume into voxels (assumed
to be of equal size) and the fact that dose is only calculated in a finite number of points, one per
voxel, makes it possible to determine a volume by counting the dose points within that volume.
Hence if we define

1 if voxel v receives more than p Gy
yv =
0 otherwise
we can model the dose volume constraint by enforcing the constraints
X
q
yv ≤
|OAR| and
100
v∈OAR
(Ax)v

≤

p + Uv yv

for all v ∈ OAR.

Here OAR is the set of voxels in the organ at risk and |OAR| is the number of voxels in the
OAR. The first constraint counts the voxels in the organ at risk having yv = 1 and makes sure
that these are at most q% of the voxels in the organ at risk. The second set of constraints
ensures that indeed only voxels receiving more than p Gy are counted in the first constraint.
Here Uv is the largest dose any voxel in the OAR can receive. Once again, these constraints
are easily incorporated in a fluence map optimization model. The AMPL code for including a
dose volume constraint on the brain stem in the example of Section 2 is given in Figure 5. The
literature on dose volume constraint models is discussed in more detail in Section 2.4 of [16]
Observing that the optimal solution found by the infinity norm model of Figure 3 in our
example treats 13 of the 33 brain stem voxels with more than 50 Gy, we have added a constraint
that at most 20% of the brain stem are to receive 50 Gy or more. This is achieved by reducing
the total monitor units to 448.39, leaving 6 brain stem voxels to receive 50 Gy or more, with a
maximal does of 51.82 Gy, but under dosing the target by up to 6.92 Gy.
The third area where integer programming models arise is in the problem of segmentation
of fluence maps for delivery of a treatment using a multileaf collimator (MLC) in step and
shoot mode. The (real) values of a fluence map are usually discretized to a small number of
fluence values. The discretized values define an integer intensity matrix I. It is then necessary
to decompose I into a number of apertures for the MLC (configurations of the MLC leaves) in
such a way that some objective (the beam-on time or monitor units, the set-up time, or the total
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Dose Volume Constraint
var y {BRNSTMVOXELS} binary;
param U {VOXELS};
param P;
param Q;
subject to VolumePercent:
sum {v in BRNSTMVOXELS} y[v] <= (Q/100) * card{BRNSTMVOXELS};
subject to DVC {v in BRNSTMVOXELS}:
sum {(a,i) in PENCILS} A[v,a,i] * x[a,i] <= P+U*y[v];

Figure 5: AMPL code for including a single dose volume constraint in fluence map optimization
models.
treatment time) is minimized. Mathematically, the integer matrix I is written as a weighted sum
of 0-1 matrices, where the 0-1 matrices represent feasible apertures and the weights represent
monitor units or beam-on time for the aperture. The objective is then to minimize the sum
of the weights (beam-on time), the number of apertures used (as a measure of set-up time), or
the sum of the weights plus some parameter times the number of apertures (measuring total
treatment time). We illustrate the problem with an example from [17].
Example 1
«
„
3 6 4
2 1 5

=

1

=

3

„

„
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0

0
1

0
1

1
0
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«
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„

„
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1

1
0

0
0

0
1

1
1

1
1

«

«
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„

„

0
0

1
0

1
1

0
1

1
0

0
0

«

«

+1

„

0
0

1
0

0
1

«

The first decomposition uses 3 apertures with a beam-on time of 7, whereas the second uses
4 apertures with a beam on time of 6.
This problem allows a great variety of integer programming formulations, depending on the
variables used. One may use binary variables to model exposed bixels, i.e. ones in the matrices
defining apertures together with (real or) integer variables to model monitor units [52]; binary
variables to model leaf positions together with binary variables to model individual monitor
units [29]; binary variables indexed by beam-on time to model the beam-on time of individual
bixels of each aperture [52] or variables counting the number of apertures and bixels receiving
a certain number of monitor units [2].
We discuss here the counter model, which follows the latter approach. Let nb ≥ 0 be integer
variables indexed by monitor units b that counts the number of apertures receiving b monitor
units. Let qijb ≥ 0 be integer variables counting the number of apertures with cell (i, j) exposed
for b monitor units, let sijb ≥ 0 be integer variables counting the number of apertures with cell
(i, j) exposed for b monitor units in excess of those apertures having cell (i, j − 1) exposed for
b monitor units. Then the decomposition problem is defined by the following constraints:
bX
max

bqijb

b=1
n
X

=

Iij for all i, j

sijb

≤

nb for all i, b

si1b

=

qi1b for all i, b

sijb

≥

qijb − qi(j−1)b for all i, b, and j ≥ 2.

j=1

(13)

The parameter bmax is an upper bound on the beam-on time any aperture can receive and
can be set to max Iij . The first constraint ensures a decomposition of I into apertures. The
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second ensures that valid apertures are defined, i.e. all ones in the matrices appear in a single
block in each row, and the last two guarantee the correct relationship between the q and s
variables.
In fact, it can be seen that the last three constraints together are the same as
Pn
j=1 max{qijb − qi(j−1)b , 0} ≤ nb for all i, b (assuming that qi0b = 0). However, this form of
the constraints is nonlinear,P
whereas (13) disaggreagtes this to linear P
constraints. Alternative
max
max
nb (minimize the
bnb (minimize beam-on time), min bb=1
objective functions are min bb=1
number of apertures), or a combination of both.
We have seen above that integer programming models for a variety of problems in radiation
oncology can be formulated easily. This discussion may have generated a few questions: If
incorporating beam angle optimization is so “simple”, why is it not widely used? Why are there
many different models for the segmentation problem? Shouldn’t any one of them suffice? We
try to address some of these questions below.
In the Operations Research community integer programming is a huge subfield. Its importance lies in the versatility of the modeling power of integer and binary variables. This versatility
comes at a price, though. As mentioned before, integer variables destroy convexity, yet solution
methods apply linear programming (i.e. convex optimization) techniques to solve subproblems,
which have to be solved often both in the branch and bound and cutting plane frameworks.
Hence solving integer programs is considerably more demanding computationally than solving
convex optimization problems, and the problem formulation has a large impact on the ability
to solve it. We highlight a few of the problems encountered.
1. Although the number of possible solutions of an IP is finite, it can be astronomically
large. We use the beam selection problem as an example. If 5 beam angles are to be
selected out of a candidate set of 360 then there are 4.9 × 1010 possible combinations.
Any algorithm to solve a combined fluence map/beam angle optimization problem needs
to implicitly enumerate all these combinations. Recalling that for each selection of beam
angles a fluence map optimization problem is solved, the enormity of the problem size
becomes evident, even acknowledging the fact that many or most combinations will never
be explicitly considered due to bounding techniques. Thus, while IP models are easily
formulated they easily become too large to be solved with current off-the-shelf hardware
and software.
2. Integer programmes are hard to solve if there are few feasible solutions or many optimal
solutions. In the first case, the solver spends a lot of computation time to find feasible
solutions. Often, once a feasible solution is found, an optimal solution can be reached
quickly. If there are many optimal solutions it may take a long time to prove optimality
because many solutions need to be checked against the incumbent, optimal solution.
3. Not all IP formulations of a problem are equally good. One important issue is the tightness
of the LP relaxation, i.e. how close the value of an optimal solution of the LP relaxation is
to the optimal value of the IP. The tighter, the better, because better lower bounds allow
more sub-problems to be discarded due to bounding. Such strong and weak formulations
sometimes differ in only a very minor aspects of the model. An indication of a “bad”
formulation is the use of “big M constraints” such as xai ≤ M wa in beam angle optimization models. From the modeling point of view, any large M will do. However, large
numbers distort the numerics of LP solution algorithms, hence should be avoided. Should
that not be possible the large M should be chosen in accordance with the problem, e.g. as
the largest allowable fluence of any bixel in the example of beam angle optimization. The
dose volume constraint models and many MLC segmentation models also contain big M
constraints [30].
Another issue is symmetry. This relates to the fact that some models allow the same solution to be feasible in different parts of the branch and bound tree. This is an undesirable
property because it severely limits the power of the bounding step. A case in point are
the variety of IP models for the MLC segmentation problem. The early model of [29]
cannot be solved for instances of clinically relevant size even with modern computers and
optimization software. It took several groups of researchers years to discover tractable
models, and those of [2, 20, 50] appear to be reaching clinically relevant problem sizes.
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4. Moreover, not all problems have the same difficulty. There is a subclass of problems that
is easy to solve, meaning that efficient algorithms, running in time polynomial in the input
size, to solve them are known and even large instances of these problems can be solved
quickly. On the other hand, there is also a big class of problems (known as NP-hard
problems) for which no such algorithm is known and is unlikely to exist. Any known
algorithm for these problems requires computation time that increases exponentially with
the size of the problem. Hence problems of clinically relevant size are difficult to solve in
reasonable time. It is not trivial to distinguish the two classes. For example, it is known
in the OR literature that the problem of minimizing beam-on time in MLC segmentation
is “easy”, i.e. solvable in polynomial time. In fact, the sweep algorithm [5] proposed in
the medical physics literature was later proved by OR researchers to solve this problem
optimally [1] and in linear time. If, however, the objective is to minimize the number of
apertures, the problem becomes NP-hard (it even belongs to a particularly hard subclass
of these problems). That is precisely the reason why this problems has become popular in
the OR community.
To summarize, the application of discrete optimization methods in radiation oncology requires careful modeling of the problems as well as care in the design of algorithms to solve those
problems. Unlike in the case of convex optimization problems it is not possible to separate the
two. This shows that close collaboration between clinical practice and Operations Research is
the way to succeed.

4

Other Problem Types

The previous two sections have introduced two of the main problem types in deterministic
OR, but the taxonomy of problems mentioned in Section 1 is substantial, and many problems
in medical physics appropriately fit in problem classes outside those that have been discussed.
Sometimes these problem areas permit an increased sophistication that better models the clinical
issue, in which case the problem might be seen as an extension of those previously discussed,
and at other times, the nature of the problem is fundamentally different. Here we introduce
conic programming, dynamic programming, constraint programming, and global optimization.
Each subsection points to applications in medical physics, resources to learn more about each
problem class, and software to model and/or solve problems.

4.1

Conic Programming

The idea behind conic programming is to extend the nonnegativity constraints of a standard
linear program. A cone is a set of elements, say K, so that if x is in K, then λx is in K for any
positive scalar λ, and a conic program looks like
min{cT x : Ax = b, x ∈ K}.
If K is the collection of nonnegative vectors, then this becomes a standard-form linear program,
but this class of problems is significantly larger since we can embed any feasibility condition.
This is due to the realization that if we have a general feasible set, say X, then K = {(λ, λx) :
x ∈ X, λ ≥ 0} is a cone that (essentially) equals X if λ = 1. With this cone, we see that
min{cT x : x ∈ X} = min{cT x : λ = 1, (λ, λx) ∈ K},
which demonstrates the modeling flexibility permitted by this problem class.
Some cones tend to be more important than others in applications, and we present a model
that has had wide practical appeal due to its modeling flexibility and due to its ability to be
solved efficiently. Specifically, we consider the second order cone, which is the collection of
n-vectors that for some j satisfy
sX
x2i ≤ xj .
i6=j
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Second order cone programs (SOCPs) are particularly useful in radiotherapy design because
they allow us to consider the inherent clinical variations that arise during treatment design
and delivery, a realization first observed in [9], which was motivated by the delivery errors
introduced from fractionating the treatment, and subsequently used in [34], which was motivated
by variations between dose models (see [54] for related work on using SOCPs to model dose
volume constraints). From a modeling perspective the idea is to consider the dose as one of
several possibilities, and the goal is to minimize the objective subject to all of the constraints
that explain the range of possible outcomes.
We consider a small example to illustrate the technique. Suppose the unit dose delivered
by two beams varies due to patient movement, realignment, and other delivery factors. Let the
fluence variables be x1 and x2 , and for the sake of simplicity, assume there are only two possible
dose considerations and two voxels. We model the problem with the following data,
2
3
0.5
0.3
2
3
6 0.45 0.28 7
–
«
»
„
A1
6
7
1/4
0
1/4
7, p =
4
5=6
.
(14)
,
and
P
=
6
7
0
3/4
3/4
4 0.3
A2
0.4 5
0.31 0.42

The rows of the unit dose matrix on the far left are separated into two matrices, A1 and A2 .
The first row of A1 explains one of the two dose scenarios for the first voxel and shows that in
this scenario the first voxel receives 0.5 Gy from beam 1 and 0.3 Gy from beam 2. The second
row describes the second scenario, in which voxel 1 receives 0.45 Gy from beam 1 and 0.28 Gy
from beam 2, assuming one monitor unit. The probability of the two scenarios is respectively
1/4 and 3/4 as listed in p, and the matrix P is conveniently the diagonal matrix corresponding
to p. Suppose the upper bounds on the dose to voxels 1 and 2 are respectively b1 = 20 and
b2 = 5. The task is to model a constraint for each voxel that restricts the probability of a dose
violation, i.e. we ask that Prob(Dv (x) > bv ) < δ, where δ is a measure of an acceptable risk of
a dose violation. The development of such a constraint is found in [9], with the resulting form
being
”
1 “
kP 1/2 (I − epT )Ai xk2 ≤ √
bi − N p T A i x ,
z N
where e is a vector of ones, N is the number of treatment fractions, bi is voxel i’s upper bound,
and z is the 1 − δ percentile of the normal distribution with mean 0 and variance 1 (large values
of z reduce the probability of violation). For the first voxel in our example with a single fraction
and z = 3, this results in
»
«
–„
–« »
– »
– „»
1/2 √ 0
x1
0.5
0.3
3/4 1/4
1 0
−
0.45 0.28
x1
3/4 1/4
0 1
0
3/2
„ «„
««
»
–„
`
´ 0.5
1
0.3
x1
≤
,
20 − 3/4, 1/4
0.45 0.28
x1
3
which after multiplication is
p
(0.019x1 + 0.008x2 )2 + (0.011x1 + 0.004x2 )2 ≤ (1/3)(20 − 0.463x1 − 0.285x2 ).
The corresponding constraint for the second voxel is
p
(0.002x1 + 0.004x2 )2 + (0.004x1 + 0.008x2 )2 ≤ (1/3)(5 − 0.308x1 − 0.415x2 ).

We mention that although the SOCP constraint for the first voxel is not linear, it is nearly the
linear constraint (0.5(1/4) + 0.45(3/4))x1 + (0.3(1/4) + 0.28(3/4))x2 ≤ 20, which ensures the
expected dose to the first voxel is less than 20 Gy. Likewise, the SOCP constraint for the second
voxel is nearly the linear constraint (0.3(1/4) + 0.31(3/4))x1 + (0.4(1/4) + 0.42(3/4))x2 ≤ 5. As
a minor point of note, this realization highlights that the first SOCP constraint is redundant
because any fluence vector x satisfying the second SOCP constraint also satisfies the first.
We incorporated SOCP constraints into the acoustic neuroma case introduced in Section 2.
Three scenarios were considered. The first assumes that each dose calculation over estimates
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SOCP
var x {PENCILS} >= 0;
var ScenarioDose {SCENARIOS, VOXELS} >= 0;
var z;
minimize WeightedDeviation: z;
subject to SOCPUpBounds {v in OARVOXELS}:
sum {sr in SCENARIOS} (sum {sc in SCENARIOS} R[sr,sc]*
(sum {(a,i) in PENCILS} Avox[sc,v,a,i]*x[a,i]))ˆ2
<= ((T[v] - NumFractions*(sum {s in SCENARIOS} p[s] *
sum {(a,i) in PENCILS} Avox[s,v,a,i]*x[a,i]))) /
(TreatmentPercentile * sqrt(NumFractions)))ˆ2;
subject to TargetLowerBound {v in TARGETVOXELS}:
sum {s in SCENARIOS} p[s] * (sum (a,i) in PENCILS Avox[s,v,a,i] * x[a,i]) >= T[v];
subject to TargetUpperBound {v in TARGETVOXELS}:
sum {s in SCENARIOS} p[s] * (sum {(a,i) in PENCILS} Avox[s,v,a,i] * x[a,i]) <= T[v] + z;

Figure 6: AMPL code for an SOCP model that calculates an optimal fluence. The R matrix in
SOCPUpBounds is P 1/2 (I − epT ), which is calculated earlier in the code.
the actual dose by 104 , the second assumes that each dose calculation is correct, and the third
assumes that the dose calculation under estimates the actual dose by 104 . Allowing A to be the
dose matrix so that D(x) = Ax, where as before a subscript can be used to indicate dose to the
indicated structure, we find that dose is D(x) = (A − 104 eeT )x for the first scenario, D(x) = Ax
for the second scenario, and D(x) = (A + 104 eeT )x for the third scenario (e is again the vector
of ones so that eeT is the matrix with each component being 1). In relation to the notation
in (14), we have a matrix with three rows for each voxel v so that
2
3
A − 104 eeT
5.
Avoxv = 4
A
A + 104 eeT

The probabilities vector was p = (1/4, 1/2, 1/4)T , and we placed an upper bound on the eye
socket of 5 Gy and an upper bound on the brain stem of 45 Gy. We assumed 30 fractions and
set the 1 − δ percentile to z = 3, which guaranteed the probability of a dose violation was at
most 0.3%. Specifically, we solved
min{kpT AP T V x − TP T V k1 :

√
kP 1/2 (I − epT )Av xk2 ≤ (5 − 30pT Av x)/3 30, v ∈ EYEVOXELS,
√
kP 1/2 (I − epT )Av xk2 ≤ (45 − 30pT Av x)/3 30, v ∈ BRNSTMVOXELS,
AP T V x ≥ 60, x ≥ 0}.

The AMPL code describing the variables, objective and constraints is located in Table 6. We
used SNOPT to find a solution through the Kestrel interface1 . The optimal solution satisfies
all the constraints and returns a treatment with the PTV receiving between 60 and 65.03 Gy.
Opposing angles at 60◦ and 240◦ were used with respectively 220.185 and 161.561 monitor units.

4.2

Dynamic Programming

Dynamic programming (DP) is concerned with time-dependent decisions that are based on an
optimal process. In some way DP bridges two of the main sub-disciplines in optimization, those
being mathematical programming and control theory. The essential difference is the type of
1 Kestrel allows AMPL to use a host of the solvers supported by NEOS, of which SNOPT is one. See http:
//www-neos.mcs.anl.gov/ for further information.

15

vector space that is used to define the optimization problem. In mathematical programming,
which is the topic of the previous sections, the decision variables are restricted to subsets of
the real line. In control theory the unknowns are instead functions with appropriate analytic
properties. If time is continuous, then the study of DP lives within variational calculus and is
more like control theory since it is defined over a collection of functions. If time is discrete,
then DP is more like staged mathematical programming, which is the case that we address here.
Interested readers are directed to [36], which presents both sub-disciplines together with their
related theoretical properties.
Since radiotherapy treatments are delivered over several fractions, the issue of time dependent
decisions arises naturally, and Deng and Ferris [13] investigate the question of adapting the
fractional doses by solving a stochastic DP. To keep with the introductory nature of this article,
we present a deterministic version to introduce DP. Adapting our earlier notation, we let Dk (x)
be the vector of doses after the kth fraction has been delivered, where x is again a vector of
fluences. If each fraction is uniform, then Dk (x) = D(x)/K, where K is the total number of
fractions. For simplicity we only consider dose and not, at least directly, its dependence on
fluence. As such, we let Dk be the vector of doses indexed by voxels after the kth fraction.
Alignment errors are modeled by linearly adjusting the dose at each fraction, and this linear
adjustment is explained by a stochastic matrix W k at each fraction. As an example, suppose
there are only 4 voxels and that
3
2
3/4 1/5
0
0
6
1/4 3/5 1/7
0 7
7.
Wk = 6
4 0
1/5 6/7 1/3 5
0
0
0
2/3
This matrix indicates that each Gray targeted at the first voxel is actually distributed to the
first two voxels, with the first voxel receiving 3/4 of the Gray and the second receiving 1/4.
Each column has a similar interpretation. If the patient had been aligned perfectly, then the
matrix would have been the identity. Assume the uniform fractional dose is supposed to be
d = (1, 2, 4, 0)T . Then the adjusted dose is
1
1 0
30
2
1.15
1
3/4 1/5
0
0
C
C B
B
6 1/4 3/5 1/7
0 7
7 B 2 C = B 2.02 C .
W kd = 6
4 0
1/5 6/7 1/3 5 @ 4 A @ 3.83 A
0.00
0
0
0
0
2/3

In this situation the first and second voxels are over treated and the third is under treated.
Instead of delivering the uniform dose, we would rather find a dose vector uk , called a control
in the study of DP and control theory, so that W k uk = d. A solution is uk = (0.8, 2.0, 4.2, 0),
and if these doses are delivered during the kth fraction, then under the patient shift indicated
by W k the desired uniform dose d is correctly delivered. An important observation is that we
are not necessarily able to find a control that always delivers the intended dose. To see this,
note that if d had been (2.8, 0.69, 1.85, 0.67)T , then the only solution to W k uk = d would have
been uk = (4, −1, 2, 1)T , which is impossible since dose can’t be removed from the second voxel.
Hence it is impossible to achieve the intended dose and some error is realized.
The central theme of control theory is to find a collection of controls that optimizes a measure
of their effectiveness. The kth control is selected from a set of possible controls appropriate for
the kth state, denoted by U k . For this problem the kth state is the cumulative dose after the
kth fraction, i.e. the kth state is Dk . Consecutive states are linked by the associated control
uk , and the dynamic iteration is
Dk+1 (uk ) = Dk + W k uk ,

(15)

where the dependence on the control uk in the left-hand side is dropped if the selection is
understood within its context of use. In the language of DP the problem is to select controls,
u1 , u2 , . . . , uk , that optimize treatment delivery. There are many measures that could be used
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to assess delivery, and our presentation is based on
K ‚
“
”‚
X
‚
‚ k−1 k−1
1
k ‚
‚W
T
−
D
u
−
‚ ,
‚
K − (k − 1)
1
k=1

This objective aggregates the errors between each fraction’s delivered dose and an updated
uniform dose, which is the difference between the optimal dose and the cumulative dose through
fraction k. Allowing
‚
“
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‚
‚ k−1 k−1
1
k ‚
f (Dk , uk−1 ) = ‚
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we aim to solve the following DP
)
(K
X
f (Dk , uk−1 ) : Dk+1 = Dk + W k uk , uk ∈ U k , k = 0, 1, 2, . . . , K .
Y (D0 ) = min

(16)

k=1

The value of this minimum, denoted by Y (D0 ), is dependent on the initial state D0 , which
is used to decide the initial control u0 . The set U k is used to guarantee that each stage’s
control is realistic, with one obvious restriction being that uk ≥ 0. Other restrictions, such as
ensuring there is a fluence that can achieve the dose, can be included. For example, U k could
be {u : Ax = u, u ≥ 0}, where A is the dose matrix so that D(x) = Ax.
Solving (16) is not trivial, but there is a marvelous technique that allows us to consider the
problem in stages. The method, which was developed by Bellman [4], shows how to establish a
recurrence relation between the optimization problems associated with consecutive states. First,
notice that u1 is a function of the first control u0 and the initial state D0 = 0, which is zero since
no dose has been delivered prior to the first fraction. Assuming (15) holds, we can streamline
presentation and re-write (16) as
))
(
(K
X
k
k−1
k
k
0
0 0
0
min f (D + W u , u ) + min
f (D , u
) : u ∈ U , k = 1, 2, . . . , K
u0 ∈U 0

=

k=2

min

u0 ∈U 0

˘

¯
˘
¯
f (W 0 u0 , u0 ) + Y (D1 ) = min f (W 0 u0 , u0 ) + Y (D0 + W 0 u0 ) .
u0 ∈U 0

(17)

The importance of this observation is that deciding an initial optimal control can, in some way,
be separated from deciding the following controls. The inner minimization problem in the first
expression is a function of D1 since this is the state from which control u1 is decided. This fact
is denoted in the next equality, and since D1 is dependent on the prior state and control, we
conclude in the final equality with notation that expresses the problem of deciding the initial
control as the minimization of the sum of two functions.
The relationship between the first two states in (17) can be continued. As an example, the
case with three fractions is

ﬀﬀ

˘
¯
.
(18)
Y (D0 ) = min f (D1 , u0 ) + min f (D2 , u1 ) + min f (D3 , u2 )
u0 ∈U 0

u1 ∈U 1

u2 ∈U 2

This expression is used to solve DPs, with the two standard methods being forward and backward
techniques, although there are several variations, see [36, 38] for further details. For simplicity
of presentation, consider the above case of three fractions and assume that U k = {u′ , u′′ } for
each k. This collection of controls is not unrealistic since u′ could represent no adjustment and
u′′ could represent a pre-calculated adjustment to a known alignment error. In this case, we are
trying to decide whether or not to adjust the patient on any particular fraction.
A schematic depicting the problem of solving the DP is shown in Figure 7. In this figure
there are two possible dose states after the first fraction, D1 (u′ ) or D1 (u′′ ), which depend on the
control used to deliver the first fraction. Similarly, there are two possible dose states following
the second [and third] fraction, D2 (u′ ) and D2 (u′′ ) [D3 (u′ ) and D3 (u′′ )]. Notice that to achieve
the dose D2 (u′ ) we could have used control u′ to deliver the first and second fractions, a course of
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treatment represented by the path from D0 to D1 (u′ ) to D2 (u′ ), or we could have alternatively
used control u′′ in the first fraction and control u′ in the second, a possibility represented
by the path from D0 to D1 (u′′ ) to D2 (u′ ). Each edge is assigned the value f (Dk (u′ ), u′ ) or
f (Dk (u′′ ), u′′ ) depending on which control is considered. So, the value of 2 on the edge from
D0 to D1 (u′′ ) shows that if we use control u′′ to deliver the first fraction, then the maximum
voxel deviation from the (updated) uniform fraction is 2 Gy, whereas the value of 1 on the edge
between D0 and D1 (u′ ) shows the maximum voxel deviation is 1 if control u′ is instead used.
This may appear as though it is better to use control u′ to deliver the first fraction, but this may
not be the case depending on the deviations imposed by this choice on the following fractions.
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Figure 8: The optimal sequences to the
possible dose states are indicated by the
thicker edges.

Figure 7: A depiction of the possible
control sequences for dynamic programming.

To solve the DP with a forward technique, we first consider the two possible dose states after
the first fraction. Since there is no choice in how to achieve these states from D0 , the edges
between D0 and D1 (u′ ) and between D0 and D1 (u′′ ) are included as part of a possible optimal
sequence of controls, which is illustrated in Figure 8 by thickening the edges. In relation to (18),
this considers both possible values of f (D1 , u0 ).
We continue by moving to the second fraction. If we select u′ , then we realize a maximum
voxel violation of either 3, in the case that u′ was used for the first fraction, or 1, in the case
that u′′ was used for the first fraction. This gives a cumulative, maximum voxel violation of
either 4 or 3, and since 3 is smaller, we know that if the optimal control sequence includes using
u′ to deliver the second fraction, then we should use u′′ in the first fraction. This information is
shown in Figure 8 as a thick edge between D1 (u′′ ) and D2 (u′ ). Notice the edge between D1 (u′ )
and D2 (u′ ) remains thin since it is not possible to use u′ for the second fraction after using u′ for
the first. A similar argument shows that if we use u′′ for the first fraction, then we should use
u′′ for the second since this gives a cumulative, maximum violation of 3 instead of 4. Returning
to the mathematical description in (18), we have decided which control u0 should be depending
on which control we use to deliver the second fraction. Importantly, we have considered all 4
possible values of f (D1 , u0 ) + f (D2 , u1 ) and discarded two, those for which u0 = u′ and u1 = u′ ,
and u0 = u′ and u1 = u′′ .
The solution procedure terminates by repeating the analysis above for the third fraction.
From the previous paragraph we know that the smallest cumulative, maximum violation after
the second fraction is 3 at either D2 (u′ ) or D2 (u′′ ). The least additional violation that can
be achieved to reach D3 (u′ ) is 2, and the edge between D2 (u′ ) and D3 (u′ ) with this value
is thickened. Likewise, we include the edge between D2 (u′′ ) and D3 (u′′ ) since this gives the
smallest cumulative, maximum violation of 4 at D3 (u′′ ). Based on our metric, we would select
the control sequence u′′ for each fraction since this minimizes the aggregate of the maximum
voxel violations over the course of treatment. An important note is that the cumulative dose
may or may not be the same at D3 (u′ ) under the control sequence u′′ for the first fraction
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and u′ for the second and third fractions. Although this sequence has a higher cumulative,
maximum deviation, these violations could occur in different voxels, and hence, it is possible
the anatomical dose is same. Indeed, the dose may in some ways be better. This observation
might seem odd since the integral dose is what is evaluated in treatment design. However, the
delivery problem is trying to best match the expected uniform fractionated dose over the entire
treatment, and since the uniformed fractions are important radiobiologically, this is reasonable.
The backwards techniques are nearly identical except that they propagate through the stages
in reverse order. The power of both methods is that they forgo a search over all possible control
sequences. In the example above, only 2 control sequences are identified out of the possible 8.
The other 6 are discarded since they can not lead to an optimal value.
Returning our focus to the clinical problem of adjusting the fractional doses to optimize
delivery, we note that the above model assumes a priori knowledge about the adjusted patient
coordinates for each fraction, i.e. the adjustment matrices W k need to be known before the adjusted fractional doses are calculated, which is not realistic. There are several imaging modalities
that support patient relocation while the patient is on the couch, but clairvoyantly forecasting
future patient positions is not possible. In this situation it makes sense to consider random patient adjustments in which each element of W k is assumed to be randomly distributed. In such
a stochastic program the objective function is a random variable, and it is natural to consider
the expected value of the objective. This is what is considered in [13]. Stochastic problems
are generally harder to solve than their deterministic counterparts, and the authors of [13] use
a technique called Neuro-Dynamic Programming to approximately solve the problem. While a
full explanation of this method is beyond the scope of this article, the essence of the method
lies in a Monte Carlo simulation that estimates the inner minimization at each iteration. The
results consistently show that the expected error is reduced by solving a DP as compared to
uniform fractions, for which improvements are significant, and to a reactionary regime that
re-calculates the next fraction as the remaining dose to be delivered divided by the number of
fractions remaining, for which there is less improvement.
Although solving a DP is not as systematic as other optimization problems, the modeling
flexibility together with the ability to handle time-dependent decisions lends itself well to many
design questions. DP has lead to major computational advances in computational biology and
has continued to be a major theme in engineering, but it has not played a significant role in
medical physics. In the authors’ opinion, this is a promising research direction that could assist
many clinical problems.

4.3

Constraint Programming

The field of constraint programming spans computer science and mathematical programming
and is concerned with the study of satisfying constraints that are stated in a natural and logical
manner. Although the focus is on constraint interrogation and satisfaction, such problems include the majority of optimization problems due to the Lagrange conditions (4). This important
area of research has not yet made a significant impact on medical physics, but since constraint
programming is focused on computing, we suspect that there is a wide-range of applications
in medical physics. We discuss the recent work in [2] and [6], which shows that constraint
programming leads to favorable results to the NP-hard problem of minimizing the number of
apertures needed to achieve an intensity map (13). For further reading, we direct interested
readers to [12] as an introduction to constraint programming.
Assuming qi0b = 0, we find that the last three constraints in (13) can be stated as
n
X
j=1

max{qijb − qi(j−1)b , 0} ≤ nb for all i, b,

and it is this aggregated constraint that counts the number of apertures that are used to deliver
the treatment. Since minimizing the number of apertures is NP-hard, this constraint is critical
to solving a computationally difficult problem, and finding small values of nb that maintain
feasibility is important. This constraint can be decomposed into linear constraints; one such
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decompositions is presented in (13), and is also used in [2], and another, which is found in [6],
is
n
X
sijb = qijb − qi(j−1)b , wijb = max{sijb , 0},
wijb ≤ nb ,
(19)
j=1

where sijb is the same as in (13) and wijb is a newly introduced variable. We want to deduce
small values of nb that subsequently lead to either optimal or near optimal objective values.
The third inequality in (19) provides a lower bound on nb , and hence, we want to search for
wijb so that the summation defining the lower bound is small and so that the overall system
remains feasible. This means we want to shrink the domains of the variables in a way that
removes non-optimal solutions. The process of reducing variable domains is called constraint
propagation in constraint programming, and an algorithm that details a specific technique is
called a propagator.
As a simple example of the deduction process, consider the case of the decomposition in (19)
for which i and b are fixed and for which there are three integer variables qi1b , qi2b , and qi3b .
Suppose that other design concerns ensure that qi1b = 0, qi2b ∈ {0, 1} and qi3b = 1. In this
situation we deduce that wi1b = 0, wi2b ∈ {0, 1} and wi3b ∈ {0, 1}, and hence, nb ≥ 2. However,
qi2b cannot be both 0 and 1, from which we see that either wi2b is 0 and wi3b is 1, or that wi2b
is 1 and wi3b is 0. This means nb ≥ 1 in actuality. In this case the variable domains/bounds
in and of themselves do not propagate to the smallest lower bound, and in such a case we say
the decomposition does not propagate completely. The decomposition in (13) similarly fails to
propagate completely.
A propagator to improve the calculation of the lower bounds on nb is presented in [6].
For each i and b, the propagator performs three passes through the j index. A forward pass
calculates a lower bound on nb that is based on the ranges of each wijb . This lower bound
is denoted by n′b . A backward pass finds a smallest and largest value of each wijb , denoted
′′
′
respectively, so that the summation of both the largest and smallest values
and wijb
by wijb
achieves the lower bound of n′b . At this point it is natural, but misleading, to think that we
have solved the segmentation problem since we have found a smallest value of each nb based
on the ranges of each wijb . However, we have not satisfied the the first constraint in (13).
′
′′
This constraint may force wijb to assume values outside [wijb
, wijb
], and the domain reduction
pass updates these bounds to reflect this necessity. The result of the propagator satisfies a
property called bounds consistency, which unfortunately is not uniquely defined [8]. P
However,
max
in this setting the property means that the lower bounds n′b and the objective value bb=1
n′b
is possibly optimal since there is an associated feasible solution that provides this objective
value. Moreover, the calculation of this value is efficient. The use of this propagator over other
decompositions impressively improves computation time, with the results in [6] showing speedup factors ranging from 2.3 to 23.8. So, even in the least successful case this propagator reduced
the solution time by over half of the other methods.

4.4

Global Optimization

Global optimization is the study of problems that may have multiple local optima, and much
of the study is about deciding which of the local optima are indeed global optima. Problems
can be continuous or discrete. The field is often concerned with solving problems that are
not directly approachable with standard and provably optimal techniques from other areas of
optimization. For example, minimizing a strictly convex, quadratic function would not be part
of the study of global optimization since there are numerous ways to solve such a problem
exactly. From this perspective, global optimization problems are among the most difficult to
solve since we typically don’t have a mathematical certificate of global optimality. However,
there are many meaningful global problems, see for example the treatment design problems
in [7] and [51] and some of the image registration problems in [42], and (approximately) solving
these problems is an important area of research. We point readers to the supplement on Global
Optimization found at the Mathematical Programming Glossary [39] and to the Handbook on
Global Optimization [35].
Global optimization’s impact on medical physics has largely been in the area of heuristic
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search, with simulated annealing and genetic algorithms being popular optimization methods,
see for example [7, 14, 22, 25, 49]. Since these methods are generally understood in the medical
physics literature, we forego a detailed discussion of these heuristics. Moreover, even a shallow
presentation of the plethora of methods within the discipline would in itself constitute a complete
review article, and our goal is to mention a couple of the central alternatives to simulated
annealing and genetic algorithms so that readers can investigate other techniques. We also
want to give a few words of caution. Heuristic methods, such as simulated annealing, are in
many ways marvelous since they accommodate nearly any optimization problem and are easily
implemented. However, they typically do not provide a guarantee of optimality, and while they
may calculate good solutions, the lack of such a guarantee eliminates a factual basis of how
much better a solution could be. We encourage readers to use exact methods that provide
such a guarantee if possible. For example, least-squares problems are convex and can be solved
efficiently with standard quadratic solvers. Simulated annealing may give an equally good
solution, but upon termination, the algorithm itself doesn’t ensure confidence that the solution
is optimal.
One collection of heuristics partitions the domain of the objective into regions and then
uses a local search method to find a local minimum. This idea works well if the function has
ascertainable analytical properties over the individual regions, a condition not always available.
Algorithmic decisions include a method to sub-divide the domain and the selection of the local
search method, which can vary from region to region. Another heuristic is tabu search by which
moves are forbidden for a few iterations of the algorithm, a paradigm that allows the method
to search portions of the domain that may at first appear less promising than others. Tabu
search is arguably the most popular meta-heuristic, which is a collection of methods that search
through the feasible region. Variations and applications are wide ranging, and we point readers
to [21].
The fact that most heuristic methods are tailored to the specific problem makes their implementation difficult to automate. However, there are a few software packages that link to
modeling systems like AMPL. Reviews of software packages are found in [41]. We specifically
mention LGO [40], which interfaces with a variety of supporting software packages like AMPL,
GAMS, MATLAB, and MAPLE. This software was used to design radiotherapy treatments
in [51].

5

Multiple Objective Problems

In the preceding sections we have discussed different types of optimization problems characterized by the mathematical properties of the objective function, the constraints, or the variables.
In this section we focus on optimization problems that contain several objective functions that
are to be minimized simultaneously. Hence (2) becomes
min{(f1 (x), . . . , fp (x)) : g(x) ≤ 0}.

(20)

Multiple objectives can be convex, discrete, or any other type of optimization problem. We
first need to specify what minimization means: Because every feasible solution is evaluated
with a vector of values, feasible solutions may not be comparable (is (1,2) smaller than (2,1) or
vice versa?). We let F (x) = (f1 (x), . . . , fp (x)) and introduce the notation of efficient solution
(or Pareto optimal solution). A feasible solution x̂ of (20) is called efficient if there does not
exist another feasible solution x such that fk (x) ≤ fk (x̂) for all k = 1, . . . , p and f (x) 6= f (x̂).
In multiobjective optimization it is useful to consider the set of all feasible outcomes. Recall
that X = {x ∈ Rn : g(x) ≤ 0} is the feasible region of (20). The function F maps X to
Y = {F (x) : x ∈ X}, the outcome set of (20). In single objective optimization Y is simply a
half-line or an interval and minimization means finding the left endpoint of that line or interval.
For optimization problems with p ≥ 2 objectives, Y exists in a p-dimensional space and there
is no such thing as a unique minimum in a p-dimensional set. All outcomes on the lower left
boundary of Y cannot be compared to each other and share the property that Y does not
contain any other outcome that is located both to the left and down from the point. We call
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those outcomes nondominated outcomes of the multiobjective optimization problem (20). An
efficient solution x ∈ X defines a nondominated outcome y = f (x) ∈ Y .
The above discussion shows that solving a multiobjective optimization problem means finding
efficient solutions of (20). This can be interpreted as finding all efficient solutions or one efficient
solution for each nondominated outcome in Y . The former is analogous to finding all optimal
solutions in a single objective optimization problem. This is different from the latter, because
there are usually many feasible solutions with the same outcome. Hence the more common
interpretation, and the one more aligned with the usual single objective practice of finding one
optimal solution, is the latter. Moving from one efficient solution to another implies that at
least one objective improves, whereas at least one deteriorates, i.e. there is a tradeoff between
the different objectives.
There are several “types” of solutions due to the sense of minimization and the difference
between the feasible region and its image under F . A feasible solution x̂ ∈ X of a multiple
objective optimization problem (20) is strictly (weakly) efficient if there is no x ∈ X such that
F (x) < F (x̂) and F (x) ≤ F (x̂) (F (x) ≤ F (x̂) and F (x) 6= F (x̂)). The outcome ŷ = F (x̂) is
called (weakly) nondominated. A strictly efficient solution x̂ does not allow another x such that
F (x) = F (x̂). Moreover, an efficient solution x̂ is called properly efficient if there is a real number
M > 0 such that for all x and i with fi (x) < fi (x̂) there is an index j such that fj (x) > fj (x̂)
and (fi (x̂) − fi (x))/(fj (x) − fj (x̂)) < M , i.e. the tradeoffs are bounded.
Example 2 We illustrate the concept of a multiple objective optimization problem with a small
example of fluence map optimization. Assume that there are only two voxels, one being a tumor
voxel to be treated with a dose of 60 Gy and the other being a organ at risk that is to receive no
radiation at all. Let the dose matrix be
«
„
0.5
0.3
,
A=
0.45 0.28
i.e. there are also only two bixels.
It is clear that it is possible to achieve the zero dose to the organ at risk with zero fluence
x = 0 and also the target dose of 60 Gy to the tumor, e.g. with x = (120, 0)T , as Ax = (60, 54).
However, the former solution does not deliver any dose and the latter does deliver 54 Gy to the
organ at risk. Applying the infinity norm model (12) with equal λ for PTV and OAR we obtain
a solution of x = (63.16, 0) with an under dose to the tumor and over dose to the organ at risk of
28.42 Gy. But these are not the only options. In fact, with every increase of x1 by one monitor
unit, the dose delivered to the tumor voxel will get 0.5 closer to 60, but the dose to the organ
at risk voxel will also increase by 0.45 and deviate away from the goal dose of 0. Hence, any
fluence x = (x1 , 0) with 0 ≤ x1 ≤ 120 is an efficient solution of a multiple objective optimization
problem, where we simultaneously minimize the under dose to the tumor voxel (say z1 ) and the
over dose to the organ at risk voxel (say z2 ). This multiple objective program is
«
«„
« „
« „
„
« „
x1
z1
60
z1
0.50 0.30
;
+
≥
min
:
0
0.45 0.28
x2
z2
z2
«„
„
« „
«
ﬀ
« „
x1
0.50 0.30
z1
−60
−
+
; x, z ≥ 0 .
≥
0.45 0.28
0
x2
z2
In fact, here the tradeoff between the two goals is constant and equals 10/9 of increase in z1
for every unit of decrease in z2 .
The methods to solve multiobjective optimization problems depend on the type of problem,
just as in the single objective case. We mention the most important facts and refer the reader to
[15] for a comprehensive introduction to multiobjective optimization. We first discuss solution
methods for convex problems. The fundamental results for convex multiobjective optimization
problems are summarized in the following theorem.
Theorem 1 Assume that all objective functions and all constraints in (20) are convex. Then
the following hold.
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1. A feasible solution x̂ is weakly efficient if and only if there is a vector λ ∈ Rp , λ ≥ 0 such
that x̂ is an optimal solution of the single objective optimization problem
)
( p
X
λk fk (x) : g(x) ≤ 0 .
(21)
min
k=1

2. A feasible solution x̂ is properly efficient if and only if there is a vector λ ∈ Rp , λ > 0 such
that x̂ is an optimal solution of (21).
3. If, moreover, all objectives and constraints are linear, then a feasible solution x̂ is efficient
if and only if there is a vector λ ∈ Rp , λ > 0 such that x̂ is an optimal solution of (21).
It is important to notice the slight differences between the three statements. In fact, convex
multiobjective optimization problems allow the characterization of weakly and properly efficient
solutions via optimal solutions of (21) – distinguished by the nonnegative and positive λ, respectively – but not that of efficient ones. For linear problems, however, all efficient solutions
are properly efficient (i.e. all trade-offs are bounded) and this difference disappears.
Theorem 1 is a powerful result when solving convex multiobjective optimization problems
because it suggests we can solve (21) by repeatedly solving the single objective problem for
different λ vectors. However, deriving algorithms from the theorem is non-trivial. For linear
multiobjective programming problems this leads to a variety of algorithms extending single
objective simplex algorithms or algorithms that attemptPto compute Y .
Noting that it is always possible to scale λ so that pk=1 λk = 1, there is a temptation to
interpret the coefficients λk as weights of importance of the objectives. However, the mathematical theory does not warrant that interpretation: The theorem does not help in constructing
a λ vector that makes a particular solution efficient, i.e. determine the weights that ensure x̂
is an optimal solution of (21). There can indeed be infinitely many (very) different λs that
result in the same efficient solution. Furthermore, slightly different λs may result in very different efficient solutions. In Example 2, noting that the problem is linear, applying the simplex
algorithm to solve the weighted sum problem will, for any choice of λ > 0, always result in
either x = (120, 0)T or x = (0, 0)T as the optimal solution. This is a property of the solution
algorithm, which needs to be kept in mind.
For nonconvex (such as discrete) optimization problems there exist efficient solutions that
are not optimal solutions of (21) as the following observation shows. Consider a multiobjective
optimization problem with three outcome vectors, i.e. X = Y = {(1, 5)T , (4, 4)T , (5, 1)T }.
Clearly minimizing λ1 x1 + λ2 x2 , or equivalently µx1 + (1 − µ)x2 (where µ = λ1 /(λ1 + λ2 )),
over X results in either (1, 5)T if 0.5 ≤ µ ≤ 1 or (5, 1) if 0 ≤ µ ≤ 0.5, but never in (4, 4)T .
Nevertheless, (4, 4)T is efficient. From this we see that the interpretation of λ as importance
weights has no meaning for nonconvex multiobjective optimization problems. Hence, methods
not relying on Theorem 1 are required.
Somewhat contrary to the lack of λ’s interpretation, the idea of identifying efficient solutions by solving substitute, single objective optimization problems is prevalent. This substitute
problem will depend on the variables, objectives, and constraints of (20) and some additional parameters, which we collect in a vector λ. The resulting single objective problem min s(f, g, x, λ)
is solved for different values of λ. This technique is called solving (20) by scalarization. Mathematically, scalarization is justified by showing that (a) for each value of λ an optimal solution of
min s(f, g, x, λ) is a (weakly, strictly, properly) efficient solution of (20) and that, vice versa, for
every (weakly, strictly, properly) efficient solution x of (20) there is a value of λ such that x is
an optimal solution of min s(f, g, x, λ). The precise mathematical properties of a scalarization
method depend on the characteristics of the multiobjective problem as well as on the properties
of s and λ. We refer to [15] and [19] for a summary of different scalarization techniques. The
most popular of those is the ε-constraint method. The idea is to convert all but one of the
objective functions of (20) into constraints fk (x) ≦ εk for k 6= j while maintaining minimization
of the objective function fj in the scalarized problem. This method can be applied to nonconvex and discrete problems, i.e. it can be shown that all efficient solutions are optimal solutions
of some ε-constraint problem. Unfortunately, the resulting single objective problems are often
hard to solve.
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Returning our discussion to medical physics, notice that the goal of radiation therapy is to
treat the tumor while at the same time protecting organs at risk and normal tissue form the
adverse effects of radiation. Thus radiotherapy pursues multiple and conflicting goals, making
the multiobjective nature self evident. The earliest multiobjective optimization models for
fluence map optimization are [11] and [27].
Consider (12). This is actually the weighted sum scalarization of Theorem 1 applied to the
multiobjective optimization problem
min {(kDP T V (x) − TP T V kp , kDST M (x) − TST M kp

kDEY E (x) − TEY E kp , kDN RM L (x) − TN RM L kp ) : x ≥ 0} .

(22)

We are assured that for every choice of the weights in (12) an efficient solution of (22) is
obtained. This means that solving (12) yields a fluence map in which not all of the p-norm
deviations from the prescripted dose for the target, organs at risk, and normal tissue can be
improved simultaneously. As mentioned in Section 2, it is necessary to choose appropriate λ
values to obtain a suitable fluence map. The multiobjective model, however, provides a wider
perspective. We first note that only efficient solutions of (22) are meaningful candidates for a
fluence map in clinical practice. The problem then becomes that of finding a suitable efficient
solution. Theorem 1 assures that this can be found with appropriate weights λ. Yet the unknown
relationship between these weights and efficient solutions often leads to a trial-and-error process
of adjusting the weights in (12) and resolving the problem until a satisfactory solution is found.
Here lies the pitfall of applying multiobjective optimization – just choosing a set of weights
and computing the corresponding solutions is not sufficient. Observing that most fluence map
optimization problems (without DVH constraints) are convex it is possible to exploit Theorem 1
and design algorithms to access the set of nondominated outcomes or efficient solutions of (22)
in a meaningful way. This approach is pursued in [28].
For the cases of the 1- and infinity-norms, problem (22) becomes a multiobjective linear
program. The research in [47] and [48] presents algorithms to approximate the nondominated
outcomes of this MOLP to any prescribed accuracy for the infinity norm case. The authors
of [46] present a method to find a finite set of efficient solutions that are guaranteed to cover the
set of nondominated outcomes well. In Figure 9 we show the nondominated set of our acoustic
neuroma case using a similar model to (22) with p = ∞, where, however, the deviations for the
brainstem and the eye are considered together as ||DO AR(x) − TOAR||p . Thus, this problem has
three objectives, and the nondominated solutions can be displayed in a 3-dimensional figure.
Note that the axes in this figure measure the maximal deviation of delivered dose from the
prescripted dose for the PTV (α), the OARs (β), and the normal tissue (γ). Figure 10 shows a
set of nondominated points from the set shown in Figure 9. Note that each point in Figure 10
defines a different treatment plan with its own characteristic tradeoffs between achieving the
target doses for the PTV, the organs at risk, and the normal tissue.
To comment briefly on a discrete multiobjective optimization problem in radiation oncology,
we refer to Example 1, where we have seen that minimizing beam-on time and minimizing setup time are contradictory objectives. Hence, the segmentation problem can be formulated as
a biobjective optimization problem. This fact has been used in [52] to solve the segmentation
problem with the objective to minimize total treatment time. The importance of this multiobjective optimization problem for clinical practice remains to be seen, however, because both
[17] and [29] observed that there are only a few efficient solutions, it appears that navigating
the tradeoffs is possible.

6

Conclusion

Optimization’s supportive role in the field of medical physics is growing, and as we have discussed
here, the spectrum of applications is wide. The essential optimization problems already applied
to clinical problems will continue to adapt to increasingly sophisticated technology, and the
complexity and size of the resulting optimization problems will grow. For this reason, the
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Figure 10: A representative set of nondominated
set from Figure 9 (from [46]).
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Figure 9: The nondominated set of a multiobjective fluence map optimization problem for the
acoustic neuroma case (from [47]).
modeling and solution methods will need to be kept current to approach clinical demand. Also,
new problems are, and will be, emerging that will require new models and possibly new solution
methods. As the medical physics community addresses these challenges, the authors hope that
this article demonstrates the value of an OR approach. We are happy to assist and encourage
readers to contact us if we can provide further insights.
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